dubobo
Lv0
0 积分
2023-09-18 加入
-
Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods
9天前
已完结
-
Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods
9天前
已完结
-
A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
16天前
已完结
-
A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
1个月前
已完结
-
Model-informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific populations
1个月前
已完结
-
A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
1个月前
已完结
-
Relationships between hemodynamic alterations and Child-Pugh Score in patients with cirrhosis
1个月前
已关闭
-
Physiologically Based Pharmacokinetic Modeling of Metformin in Children and Adolescents With Obesity
1个月前
已完结
-
CYP3A inhibitor itraconazole affect pharmacokinetic behavior of famitinib and its active metabolite: results of a single-center, single-arm, open-label and fixed sequence study
1个月前
已完结
-
Pharmacokinetics of Henagliflozin in Dialysis Patients with Diabetes
2个月前
已完结